Showing results (1-10 of 81) with videos related to
Sort By:
Pageof 9
Kardiologiia|August 22, 2022
[Three ages of spironolactone. Evolution of views on spironolactone capabilities in the treatment of patients with heart failure.]F T AgeevKardiologiia|May 26, 2009
[Effect of various approaches to therapy with statins in high risk patients from the point of view of vascular endothelium]B D Kulev, F T AgeevKardiologiia|April 16, 2023
[Diastolic heart failure: 20 years later. Сurrent issues of pathoge-nesis, diagnosis and treatment of heart failure with preserved LVEF]F T Ageev, A G OvchinnikovKardiologiia|November 24, 2020
[The Choice of Priorities in Contemporary Comparative Trials: Superiority vs non Inferiority. Causes and Effects]F T Ageev, E B YarovayaKardiologiia|May 22, 2018
[Heart failure with preserved left ventricular ejection fraction: epidemiology, patient «portrait», clinic and diagnostics]S V Gavryushina, F T AgeevTerapevticheskii Arkhiv|December 8, 2011
[Multicenter trial of olmesartan. Main results]F T Ageev, O N SviridaKardiologiia|August 22, 2022
[Treatment of patients with heart failure and preserved ejection fraction: reliance on clinical phenotypes]F T Ageev, A G OvchinnikovTerapevticheskii Arkhiv|April 7, 2010
[Arterial stiffness as a predictor of cardiovascular events in coronary heart disease]Ia A Orlova, F T AgeevKardiologiia|November 16, 2023
[Heart Failure With Low and Preserved Left Ventricular Ejection Fraction - are These Two Different Independent Diseases or One Disease, but at Different Stages of its Progression? How Does This Affect the Choice of Therapy and Its Effectiveness?]F T Ageev, A G OvchinnikovPageof 9